论文部分内容阅读
克利夫兰消息:由心脏上腔产生的强效激素心房促尿钠排泄因子(ANF)的早期临床试验结果正在表明,此因子是一种强利尿和促尿钠排泄化合物,也是一种潜在的降压剂而无现有抗高血压制剂的缺点。许多世界研究中心的初步研究表明,ANF可作为自身容量调节因子,通过主动诱导肾钠和水的排泄,保护机体避免体液过多,并通过其血管扩张作用,降低血压。此外,ANF可帮助检出将要患高血压的盐敏感病人。
CLEVELAND: Early clinical trials of atrial-derived atrial natriuretic peptide (ANF), a potent hormone produced by the superior cardiac cavity, are showing that this factor is a potent diuretic and natriuretic compound and a potential antihypertensive Without the disadvantages of existing anti-hypertensive agents. Preliminary studies in many World Centers of Research show that ANF acts as a regulator of its own capacity to protect the body from excess body fluid by actively inducing renal sodium and water excretion and to reduce blood pressure through its vasodilator effects. In addition, ANF can help detect salt-sensitive patients who will develop high blood pressure.